During the past decade, Uniwersytecki Dzieciecy Szpital Kliniczny im. L. Zamenhofa conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 4 clinical trials were completed, i.e. on average, 80% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 2 clinical trials were completed. i.e. 66.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Uniwersytecki Dzieciecy Szpital Kliniczny im. L. Zamenhofa" #1 sponsor was "Allergan" with 2 trials, followed by "Pfizer" with 2 trials sponsored, "Bayer" with 1 trials sponsored, "Otsuka Pharmaceutical Development & Commercialization, Inc." with 1 trials sponsored and "Takeda" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Uniwersytecki Dzieciecy Szpital Kliniczny im. L. Zamenhofa" #1 collaborator was "PRA Health Sciences" with 1 trials as a collaborator and "Takeda Development Center Americas, Inc." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Uniwersytecki Dzieciecy Szpital Kliniczny im. L. Zamenhofa" are "Cerebral Palsy" (2 trials), "Muscle Spasticity" (2 trials), "Pediatrics" (2 trials), "Autosomal Recessive Polycystic Kidney (ARPKD)" (1 trials) and "Chronic Kidney Disease" (1 trials). Many other conditions were trialed in "Uniwersytecki Dzieciecy Szpital Kliniczny im. L. Zamenhofa" in a lesser frequency.

Most popular intervention types in "Uniwersytecki Dzieciecy Szpital Kliniczny im. L. Zamenhofa" are "Drug" (5 trials) and "Biological" (3 trials). Other intervention types were less common.

The name of intervention was led by "13-valent pneumococcal conjugate vaccine" (1 trials), "20-valent pneumococcal conjugate vaccine" (1 trials), "Botulinum Toxin Type A" (1 trials), "Cefepime" (1 trials) and "Ceftazidime -avibactam" (1 trials). Other intervention names were less common.

The vast majority of trials in "Uniwersytecki Dzieciecy Szpital Kliniczny im. L. Zamenhofa" are 7 trials for "All" genders.

Currently, there are NaN active trials in "Uniwersytecki Dzieciecy Szpital Kliniczny im. L. Zamenhofa". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Uniwersytecki Dzieciecy Szpital Kliniczny im. L. Zamenhofa, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Uniwersytecki Dzieciecy Szpital Kliniczny im. L. Zamenhofa, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".